[1]
2025. Development and in Vitro Evaluation of Hydrophilic and Hydrophobic Polymer-Based Sustained Release Matrix Tablets of Fosfomycin for the Prolonged Management of Recurrent Urinary Tract Infections. International Journal of Environmental Sciences. (Sep. 2025), 1382–1393. DOI:https://doi.org/10.64252/j1hm1d59.